TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
379,564
|
428,897
|
454,786 |
| Financial expenses |
16
|
54
|
285 |
| Earnings before taxes |
15,074
|
16,441
|
16,035 |
| EBITDA |
14,121
|
15,268
|
16,505 |
| Total assets |
168,827
|
169,784
|
167,400 |
| Current assets |
168,553
|
169,657
|
167,158 |
| Current liabilities |
32,348
|
40,411
|
51,135 |
| Equity capital |
128,371
|
120,823
|
107,651 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
23
|
28
|
31 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
71.2%
|
64.3% |
| Turnover per employee |
16,503
|
15,318
|
14,671 |
| Profit as a percentage of turnover |
4.0%
|
3.8%
|
3.5% |
| Return on assets (ROA) |
8.9%
|
9.7%
|
9.7% |
| Current ratio |
521.1%
|
419.8%
|
326.9% |
| Return on equity (ROE) |
11.7%
|
13.6%
|
14.9% |
| Change turnover |
-35,147
|
-28,231
|
-55,864 |
| Change turnover % |
-8%
|
-6%
|
-11% |
| Chg. No. of employees |
-5
|
-3
|
0 |
| Chg. No. of employees % |
-18%
|
-10%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.